Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Zuber

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Current Opinion in Organ Transplantation|October 6, 2011
Harnessing regulatory T cells for transplant tolerance in the clinic through mTOR inhibition: myth or reality?Julien Zuber, Olivier Hermine, Lucienne Chatenoud, et al.
Ejhaem|February 23, 2023
B12 deficiency or thrombotic microangiopathy? The key is in the peripheral smearNelly Alanbari, Quentin Amiot, Julien Zuber, et al.
The Lancet. Oncology|July 9, 2022
Managing immune checkpoint inhibition in transplant recipientsCéleste Lebbé, Lucie Biard, Julie Delyon, et al.
Current Opinion in Organ Transplantation|July 11, 2013
Physiological and therapeutic complement regulators in kidney transplantationLubka T Roumenina, Julien Zuber, Véronique Frémeaux-Bacchi
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 6, 2024
Belatacept-related cytomegalovirus infection: Advocacy for tailored immunosuppression based on individual assessment of immune fitnessJulien Zuber, Juliette Leon, Julie Déchanet-Merville, et al.
Lancet (London, England)|March 1, 2017
Haemolytic uraemic syndromeFadi Fakhouri, Julien Zuber, Véronique Frémeaux-Bacchi, et al.
Clinical Transplants|June 8, 2010
Bortezomib alone fails to decrease donor specific anti-HLA antibodies: 4 case reportsRebecca Sberro-Soussan, Julien Zuber, Caroline Suberbielle-Boissel, et al.
Autoimmunity Reviews|April 19, 2026
Bispecific T-cell engagers in autoimmune diseases: mechanisms of action, clinical evidence challenges, and therapeutic perspectivesMarion Larue, Samuel Bitoun, Julien Zuber, et al.
Medicine|August 10, 2002
Alpha-interferon-associated thrombotic microangiopathy: a clinicopathologic study of 8 patients and review of the literatureJulien Zuber, Frank Martinez, Dominique Droz, et al.
Transplantation|July 30, 2014
Diarrhea after kidney transplantation: a new look at a frequent symptomFlorence Aulagnon, Anne Scemla, Susan DeWolf, et al.
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Current Opinion in Organ Transplantation|October 6, 2011
Harnessing regulatory T cells for transplant tolerance in the clinic through mTOR inhibition: myth or reality?Julien Zuber, Olivier Hermine, Lucienne Chatenoud, et al.
Ejhaem|February 23, 2023
B12 deficiency or thrombotic microangiopathy? The key is in the peripheral smearNelly Alanbari, Quentin Amiot, Julien Zuber, et al.
The Lancet. Oncology|July 9, 2022
Managing immune checkpoint inhibition in transplant recipientsCéleste Lebbé, Lucie Biard, Julie Delyon, et al.
Current Opinion in Organ Transplantation|July 11, 2013
Physiological and therapeutic complement regulators in kidney transplantationLubka T Roumenina, Julien Zuber, Véronique Frémeaux-Bacchi
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 6, 2024
Belatacept-related cytomegalovirus infection: Advocacy for tailored immunosuppression based on individual assessment of immune fitnessJulien Zuber, Juliette Leon, Julie Déchanet-Merville, et al.
Lancet (London, England)|March 1, 2017
Haemolytic uraemic syndromeFadi Fakhouri, Julien Zuber, Véronique Frémeaux-Bacchi, et al.
Clinical Transplants|June 8, 2010
Bortezomib alone fails to decrease donor specific anti-HLA antibodies: 4 case reportsRebecca Sberro-Soussan, Julien Zuber, Caroline Suberbielle-Boissel, et al.
Autoimmunity Reviews|April 19, 2026
Bispecific T-cell engagers in autoimmune diseases: mechanisms of action, clinical evidence challenges, and therapeutic perspectivesMarion Larue, Samuel Bitoun, Julien Zuber, et al.
Medicine|August 10, 2002
Alpha-interferon-associated thrombotic microangiopathy: a clinicopathologic study of 8 patients and review of the literatureJulien Zuber, Frank Martinez, Dominique Droz, et al.
Transplantation|July 30, 2014
Diarrhea after kidney transplantation: a new look at a frequent symptomFlorence Aulagnon, Anne Scemla, Susan DeWolf, et al.
Pageof 12